Literature DB >> 22086137

High glucose concentrations alter the biomineralization process in human osteoblastic cells.

A García-Hernández1, H Arzate, I Gil-Chavarría, R Rojo, L Moreno-Fierros.   

Abstract

Diabetes mellitus (DM) may alter bone remodeling, as osteopenia and osteoporosis are among the complications. Moreover, DM increases the risk and severity of chronic inflammatory periodontal disease, in which bone resorption occurs. Broad evidence suggests that chronic inflammation can contribute to the development of DM and its complications. Hyperglycemia is a hallmark of DM that may contribute to sustained inflammation by increasing proinflammatory cytokines, which are known to cause insulin resistance, via toll-like receptor (TLR)-4-mediated mechanisms. However, the mechanisms by which bone-related complications develop in DM are still unknown. Studies done on the effect of high glucose concentrations on osteoblast functions are contradictory because some suggest increases (although others suggest reductions) in the biomineralization process. Therefore, we evaluated the effect of high glucose levels on biomineralization and inflammation markers in a human osteoblastic cell line. Cells were treated with either physiological 5.5 mM or increasing concentrations of glucose up to 24 mM, and we determined the following: i) the quantity and quality of calcium-deposit crystals in culture and ii) the expression of the following: a) proteins associated with the process of biomineralization, b) the receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG), c) cytokines IL1, IL6, IL8, IL10, MCP-1 and TNF alpha, and d) TLR-2, -3, -4 and -9. Our results show that high glucose concentrations (12 mM and particularly 24 mM) alter the biomineralization process in osteoblastic cells and provoke the following: i) a rise in mineralization, ii) an increase in the mRNA expression of RANKL and a decrease of OPG, iii) an increase in the mRNA expression of osteocalcin, bone sialoprotein and the transcription factor Runx2, iv) a diminished quality of the mineral, and v) an increase in the expression of IL1beta, IL6, IL8, MCP-1 and IL10 mRNAs. In addition we found that both high glucose levels and hyperosmotic conditions provoked TLR-2, -3, -4 and -9 overexpression in osteoblastic cells, suggesting that they are susceptible to osmotic stress.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086137     DOI: 10.1016/j.bone.2011.10.032

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  51 in total

1.  25-Hydroxyvitamin D(3)-loaded PLA microspheres: in vitro characterization and application in diabetic periodontitis models.

Authors:  Hao Li; Qi Wang; Yu Xiao; Chongyun Bao; Wei Li
Journal:  AAPS PharmSciTech       Date:  2013-05-08       Impact factor: 3.246

2.  Update on type 2 diabetes-related osteoporosis.

Authors:  Kannikar Wongdee; Narattaphol Charoenphandhu
Journal:  World J Diabetes       Date:  2015-06-10

3.  Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures.

Authors:  U Heilmeier; D R Carpenter; J M Patsch; R Harnish; G B Joseph; A J Burghardt; T Baum; A V Schwartz; T F Lang; T M Link
Journal:  Osteoporos Int       Date:  2015-01-13       Impact factor: 4.507

4.  Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.

Authors:  Naiomy D Rios-Arce; Andrew Dagenais; Derrick Feenstra; Brandon Coughlin; Ho Jun Kang; Susanne Mohr; Laura R McCabe; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2019-09-19       Impact factor: 6.384

5.  MiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway.

Authors:  Li You; Wensha Gu; Lin Chen; Ling Pan; Jinyu Chen; Yongde Peng
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 6.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

7.  Interactions between mesenchymal stem cells, adipocytes, and osteoblasts in a 3D tri-culture model of hyperglycemic conditions in the bone marrow microenvironment.

Authors:  Torri E Rinker; Taymour M Hammoudi; Melissa L Kemp; Hang Lu; Johnna S Temenoff
Journal:  Integr Biol (Camb)       Date:  2014-01-24       Impact factor: 2.192

Review 8.  Diabetes and Its Effect on Bone and Fracture Healing.

Authors:  Hongli Jiao; E Xiao; Dana T Graves
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

Review 9.  Diabetes mellitus and osteoporosis.

Authors:  Robert Sealand; Christie Razavi; Robert A Adler
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

10.  Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study.

Authors:  J I-H Chiang; T-C Li; C-I Li; C-S Liu; N-H Meng; W-Y Lin; S-Y Yang; H-J Chen; C-C Lin
Journal:  Osteoporos Int       Date:  2016-06-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.